Advertisement

Pharmacology of the sympathetic nervous system

  • A. Carlsson

Abstract

Drugs may interfere with the efferent sympathetic system, mainly at four different levels: 1) the sympathetic centres (and these in turn are located at different levels), 2) the sympathetic ganglia, 3) the postganglionic sympathetic nerve-endings, and 4) the effector cells (smooth muscle, heart, glands, etc.). In general their actions are brought about by interference with neurohumoral transmission mechanisms — at least peripherally, but probably also centrally. In the periphery, essentially two transmitters are involved, namely noradrenaline (N.A.) in the postganglionic fibres, and acetylcholine in the preganglionic fibres. However, some postganglionic sympathetic fibres are cholinergic. Some of them have a vasodilator function, but there are certain reasons to doubt that they are of any great importance in primates (Uvnäs, 1964). To complicate the matter further, N.A.-containing fibres have been found, with the aid of the new histochemical fluorescence method of visualising N.A. and related compounds developed by the late N.-Å. Hillarp and his co-workers, to terminate in sympathetic ganglia (Hamberger et al., 1963, 1965), and in parasympathetic ganglia, too, for that matter (Norberg, 1964; Hamberger and Norberg, 1965).

Keywords

Sympathetic Nervous System Sympathetic Ganglion Sympathetic System Adrenergic Nerve Acta Physiol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Åblad, B.: Acta pharmac. tox. 20, Suppl. 1 (1963).Google Scholar
  2. Andén, N.-E., A. Carlsson, and N.-Å. Hillarp: Acta pharmac. tox. 21, 183 (1964).CrossRefGoogle Scholar
  3. Andén, N.-E., and M. Henning: to be published (1965).Google Scholar
  4. Andén, N.-E., and T. Magnusson: In: Pharmacology of Cholinergic and Adrenergic Transmission. Proc. 2nd Internat. Pharmacol. Meeting, Prague, 1963. Ed. by G. B. Koelle, W. W. Douglas, and A. Carlsson. Pergamon Press, Oxford, 1965, 3, p. 319.Google Scholar
  5. Carlsson, A.: In: Handbuch der experimentellen Pharmakologie. Ergänzungswerk. Ed. by V. Erspamer. Springer, Berlin, 1965 a, in press.Google Scholar
  6. Carlsson, A.: Physiological and pharmacological release of monoamines in the central nervous system. Paper read at Internat. Symposium on Release of Biogenic Amines. Stockholm, Sweden, February 1965b.Google Scholar
  7. Carlsson, A., B. Falck, K. Fuxe, and N.-Å. Hillarp: Acta physiol. Scand. 60, 112 (1964).PubMedCrossRefGoogle Scholar
  8. Carlsson, A., and M. Lindqvist: Acta physiol. Scand. 54, 87 (1962).PubMedCrossRefGoogle Scholar
  9. Carlsson, A., and B. Waldeck: Acta pharmac. tox. 22, 293 (1965).CrossRefGoogle Scholar
  10. Costa, E., A. M. Revzin, R. Kuntzman, S. Spector, and B. Brodie: Science 133, 1822 (1961).PubMedCrossRefGoogle Scholar
  11. Crout, J. R., and P. A. Shore: Personal communication (1965).Google Scholar
  12. Davis, R. A., D. J. Drain, M. Horlington, R. Lazare, and A. Urbanska: Life Sc. 3, 193 (1963).CrossRefGoogle Scholar
  13. Fuxe, K., and G. Sedvall: Acta physiol. Scand. 64, 75 (1965).PubMedCrossRefGoogle Scholar
  14. Hamberger, B., and K. A. Norberg: Internat. J. Neuropharmacol. 4, 41 (1965).CrossRefGoogle Scholar
  15. Hamberger, B., K. A. Norberg, and F. Sjöqvist: Internat. J. Neuropharmacol. 2, 279 (1963).CrossRefGoogle Scholar
  16. Hamberger, B., K. A. Norberg, and U. Ungerstedt: Acta physiol. Scand. 64, 285 (1965).PubMedGoogle Scholar
  17. Häggendal, J., and M. Lindqvist: Acta physiol. Scand. 60, 351 (1963).CrossRefGoogle Scholar
  18. Löfving, B.: Acta physiol. Scand. 53, Suppl. 184 (1961).Google Scholar
  19. Malmfors, T.: Acta physiol. Scand. 64, Suppl. 248 (1965).Google Scholar
  20. Muscholl, E.: In: Pharmacology of Cholinergic and Adrenergic Transmission. Proc. 2nd Internat. Pharmacol. Meeting, Prague, 1963. Ed by G. B. Koelle, W. W. Douglas, and A. Carlsson. Pergamon Press, Oxford, 1965, 3, p. 291.Google Scholar
  21. Norberg, K. A.: Internat. J. Neuropharmacol. 3, 379 (1964).CrossRefGoogle Scholar
  22. Pletscher, A., K. F. Gey, and P. Zeller: Fortschr. Arzneimittelforsch. 2, 417 (1960).PubMedGoogle Scholar
  23. Reinert, H.: J. Physiol. 167, 18 (1963).PubMedGoogle Scholar
  24. Roos, B.-E., and B. Werdinius: Life Sc. 2, 92 (1963).CrossRefGoogle Scholar
  25. Rosengben, E.: Acta physiol. Scand. 49, 364 (1960).CrossRefGoogle Scholar
  26. Uvnäs, B.: Personal communication (1964).Google Scholar
  27. Vogt, M.: J. Physiol. 123, 451 (1954).PubMedGoogle Scholar

Copyright information

© Springer-Verlag · Berlin · Heidelberg 1966

Authors and Affiliations

  • A. Carlsson

There are no affiliations available

Personalised recommendations